B James Breitmeyer

Affiliations

  • Chief Executive Officer at Oncternal Therapeutics Inc. (ONCT), 2024-02-15
  • Director at Otonomy Inc. (OTIC), 2022-06-23
  • Director at Zogenix Inc. (ZGNX), 2022-03-10
  • Evp, Cmo at Cadence Pharmaceuticals Inc (CADX), 2012-03-16
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ONCT $0.29 2,250 $652.50 196,544 2023-04-14 Filing
ONCT $0.30 47,750 $14,277.25 194,294 2023-04-14 Filing
ONCT $0.29 100,000 $29,000.00 146,544 2023-04-13 Filing
ONCT $1.68 25,000 $42,080.00 46,544 2022-01-27 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ZGNX $50.00 5,000 $250,000.00 1,250 2019-12-16 Filing
ZGNX $50.00 5,000 $250,000.00 1,250 2019-11-25 Filing
CADX $5.70 12,500 $71,303.75 10,000 2011-11-03 Filing
CADX $8.99 3,000 $26,970.00 10,000 2011-07-11 Filing
CADX $8.35 12,000 $100,162.80 10,000 2011-05-02 Filing